Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
All people
Albert Muñoz-Vendrell
Sort by Type
Date
Speaker
ePoster
P101
Switching anti-CGRP monoclonal antibodies benefits 25% of non-responders – an observational study of 82 cases
Further involvements
ePoster
P046
Lacosamide, gabapentin, and baclofen as second-line treatments for trigeminal neuralgia – a retrospective comparison of treatment strategies
ePoster
P012
Effectiveness and safety of anti-CGRP treatment in migraine patients with autoimmune diseases: multicenter "ImmunoCGRP" case-control study
ePoster
P110
Concomitant anti-CGRP drug and immunomodulator treatment in patients with autoimmune diseases: results of the multicenter "ImmunoCGRP" study on migraine
ePoster
P101
Switching anti-CGRP monoclonal antibodies benefits 25% of non-responders – an observational study of 82 cases
ePoster
P236
Idiopathic or Secondary Intracranial Hypertension – a comparison of demographic, clinical and etiological factors
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy